Alyeska Investment Group
AERI

Alyeska Investment Group’s Aerie Pharmaceuticals AERI Stock Holding History

Alyeska Investment Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,000
Closed -$750K – 672
2022
Q2 		$750K Hold
100,000
– – 0.01% 509
2022
Q1 		$910K Buy
+100,000
New +$771K 0.01% 526
2021
Q1 		– Sell
-206,551
Closed -$2.79M – 877
2020
Q4 		$2.79M Sell
206,551
-1,652
-0.8% -$20K 0.04% 346
2020
Q3 		$2.45M Hold
208,203
– – 0.04% 328
2020
Q2 		$3.07M Sell
208,203
-29,270
-12% -$433K 0.05% 321
2020
Q1 		$3.21M Buy
237,473
+70,946
+43% +$1.35M 0.06% 230
2019
Q4 		$4.03M Buy
166,527
+632
+0.4% +$13.1K 0.05% 244
2019
Q3 		$3.19M Buy
165,895
+42,994
+35% +$985K 0.05% 261
2019
Q2 		$3.63M Buy
+122,901
New +$4.74M 0.05% 268
2019
Q1 		– Sell
-98,000
Closed -$3.54M – 471
2018
Q4 		$3.54M Buy
+98,000
New +$4.6M 0.05% 250
2018
Q3 		– Sell
-84,288
Closed -$5.69M – 545
2018
Q2 		$5.69M Sell
84,288
-216,815
-72% -$12.1M 0.05% 264
2018
Q1 		$16.3M Buy
301,103
+164,976
+121% +$9.23M 0.14% 178
2017
Q4 		$8.13M Sell
136,127
-55,155
-29% -$3.34M 0.06% 227
2017
Q3 		$9.3M Buy
191,282
+131,282
+219% +$7.16M 0.07% 250
2017
Q2 		$3.15M Buy
60,000
+33,442
+126% +$1.56M 0.03% 313
2017
Q1 		$1.2M Sell
26,558
-78,070
-75% -$3.48M 0.01% 427
2016
Q4 		$3.96M Sell
104,628
-29,323
-22% -$1.11M 0.03% 346
2016
Q3 		$5.05M Buy
+133,951
New +$2.95M 0.05% 319
2014
Q4 		– Sell
-24,927
Closed -$516K – 545
2014
Q3 		$516K Buy
+24,927
New +$491K 0.01% 358
2014
Q1 		– Sell
-51,508
Closed -$925K – 413
2013
Q4 		$925K Buy
+51,508
New +$671K 0.04% 274

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group's AERI Position: Q3 2022 in Review

Alyeska Investment Group sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 100,000 shares — an estimated $750K sold.

Alyeska Investment Group first reported a position in AERI in Q4 2013 and held it in 20 quarters. The position peaked at $16.3M in Q1 2018. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Alyeska Investment Group reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 100,000 Aerie Pharmaceuticals shares in Q3 2022, an estimated $750K.
  • Alyeska Investment Group first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 20 quarters.
  • Alyeska Investment Group's Aerie Pharmaceuticals position peaked at $16.3M in Q1 2018.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.